What is the recommended tapering schedule for fluoxetine (selective serotonin reuptake inhibitor) 60mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tapering Fluoxetine 60mg

Fluoxetine 60mg can be tapered more rapidly than other SSRIs due to its long half-life, with a recommended schedule of reducing by 20mg every 2-4 weeks until reaching 20mg, then reducing by 10mg for 1-2 weeks, followed by complete discontinuation. 1, 2

Understanding Fluoxetine's Pharmacological Advantage

  • Fluoxetine has an extended half-life (1-3 days for the parent compound and 7-15 days for its active metabolite norfluoxetine), making it less likely to cause withdrawal symptoms compared to other SSRIs 2
  • Unlike other SSRIs that require very gradual tapering, fluoxetine's long half-life creates a natural taper effect even after complete discontinuation 2, 3
  • This unique pharmacokinetic profile means fluoxetine can be tapered more rapidly than other serotonin reuptake inhibitors without significantly increasing discontinuation symptoms 2, 4

Recommended Tapering Schedule for Fluoxetine 60mg

Step 1: Initial Dose Reduction

  • Reduce from 60mg to 40mg daily and maintain for 2-4 weeks 1
  • Monitor for any emergence of withdrawal symptoms during this period 1

Step 2: Intermediate Reduction

  • Reduce from 40mg to 20mg daily and maintain for 2-4 weeks 1, 2
  • The 20mg dose is often used as a key transition point in the taper 1

Step 3: Final Reduction

  • Reduce from 20mg to 10mg daily for 1-2 weeks 1
  • Some patients may benefit from a brief period at 5mg if commercially available or if tablets can be split 1, 3

Step 4: Discontinuation

  • After 1-2 weeks at the lowest dose, fluoxetine can be discontinued completely 1, 2
  • The long half-life of fluoxetine and its active metabolite will continue to provide a natural taper effect 2

Monitoring and Management of Withdrawal Symptoms

  • Common withdrawal symptoms may include dizziness, fatigue, nausea, headaches, sensory disturbances, anxiety, irritability, and sleep disturbances 1, 2
  • Withdrawal symptoms with fluoxetine are typically milder and have delayed onset compared to other SSRIs due to its long half-life 2, 4
  • If significant withdrawal symptoms occur, return to the previous dose and slow the taper rate 1

Important Clinical Considerations

  • The timing of tapering should avoid periods of high stress when possible 1
  • Consider adjunctive cognitive-behavioral therapy during the tapering process to increase success rates 1
  • Patients should be informed that withdrawal symptoms, if they occur, are generally mild and self-limiting with fluoxetine 2
  • Regular follow-up during the tapering process is recommended to assess for both withdrawal symptoms and potential relapse of the underlying condition 1

Special Situations

  • For patients with a history of severe withdrawal symptoms from previous antidepressant discontinuation attempts, an even more gradual taper may be considered 3
  • Patients with comorbid anxiety disorders may benefit from a slower taper as they may be more sensitive to discontinuation effects 1
  • If withdrawal symptoms become problematic despite the taper, temporarily reinstating the previous dose and then proceeding with a more gradual reduction is recommended 1, 3

References

Guideline

Tapering and Discontinuing Paroxetine 10 mg

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.